Rachel A. Freedman, Melissa E. Hughes, Rebecca A. Ottesen, Jane C. Weeks, Yulei He, Yu-Ning Wong, Richard Theriault and Nancy L. Keating Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network Cancer 119
Version of Record online: 25 SEP 2012 | DOI: 10.1002/cncr.27831
The authors report differences in the rate at which patients complete treatment with trastuzumab according to race and education among women who receive treatment at National Comprehensive Cancer Network centers. Efforts to assure the appropriate use of trastuzumab and to understand treatment barriers are needed and may lead to improved outcomes.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field